Endonovo Announces Distribution Agreement with Academy Medical
06 mars 2023 09h07 HE
|
Endonovo Therapeutics, Inc.
Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a...
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
28 févr. 2023 09h09 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today...
Endonovo Partners with International Distributor for SofPulse® Line
26 janv. 2023 09h03 HE
|
Endonovo Therapeutics, Inc.
Partnership Expected to Increase SofPulse® Distribution and Revenues Los Angeles, CA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced a new...
Endonovo Launches Telehealth Initiative
13 déc. 2022 09h11 HE
|
Endonovo Therapeutics, Inc.
Expands Patient Education, Access to Non-Opioid Options for Pain Management Los Angeles, CA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the...
Proactive Healthcare Launch New Website Which Offers Customers A Chance To Win Rewards with Their Loyalty Programme
07 déc. 2022 09h00 HE
|
Proactive Healthcare
Ballymoney, UK, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Established in 1997, Proactive Healthcare is a leading online supplier of health supplements and equipment. Their mission is to help people...
Endonovo Names Ira Weisberg President to Guide Global Medical Expansion
30 nov. 2022 09h07 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today named Ira Weisberg as President and Chief Commercial Officer of its Medical Division. “Ira will...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
28 juil. 2022 09h08 HE
|
Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products
25 avr. 2022 09h08 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA – a leading Global Contract Research Organization (CRO) and...
$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursement
11 avr. 2022 09h08 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 11, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced significant advancement in the of process to obtain medical reimbursements for its...
Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulse® Devices Moves Forward
11 mai 2021 08h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced completion of Shipment of SofPulse® tPEMF Devices for use in...